These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23937549)

  • 21. Health outcomes of asymptomatic HIV-infected pregnant women initiating antiretroviral therapy at different baseline CD4 counts in Ethiopia.
    Ejigu Y; Magnus JH; Sundby J; Magnus M
    Int J Infect Dis; 2019 May; 82():89-95. PubMed ID: 30802623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis.
    Ndawinz JD; Chaix B; Koulla-Shiro S; Delaporte E; Okouda B; Abanda A; Tchomthe S; Mboui E; Costagliola D; Supervie V
    J Antimicrob Chemother; 2013 Jun; 68(6):1388-99. PubMed ID: 23391713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008.
    Althoff KN; Buchacz K; Hall HI; Zhang J; Hanna DB; Rebeiro P; Gange SJ; Moore RD; Kitahata MM; Gebo KA; Martin J; Justice AC; Horberg MA; Hogg RS; Sterling TR; Cescon A; Klein MB; Thorne JE; Crane HM; Mugavero MJ; Napravnik S; Kirk GD; Jacobson LP; Brooks JT;
    Ann Intern Med; 2012 Sep; 157(5):325-35. PubMed ID: 22944874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors informing HIV providers' decisions to start antiretroviral therapy for young people living with behaviorally acquired HIV.
    Lee L; Rand CS; Ellen JM; Agwu AL
    J Adolesc Health; 2014 Sep; 55(3):358-65. PubMed ID: 24794054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata.
    Palella FJ; Deloria-Knoll M; Chmiel JS; Moorman AC; Wood KC; Greenberg AE; Holmberg SD;
    Ann Intern Med; 2003 Apr; 138(8):620-6. PubMed ID: 12693883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in early initiation of antiretroviral therapy and characteristics of persons with HIV initiating therapy in San Francisco, 2007-2011.
    Hsu LC; Truong HM; Vittinghoff E; Zhi Q; Scheer S; Schwarcz S
    J Infect Dis; 2014 May; 209(9):1310-4. PubMed ID: 24218501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of CD4 Cell Counts and Viral Load Testing on Mortality Rates in Patients With HIV Infection Receiving Antiretroviral Treatment: An Observational Cohort Study in Rural Southwest China.
    Shen Z; Zhu Q; Tang Z; Pan SW; Zhang H; Jiang H; Chen Y; Lan G; Xing H; Liao L; Feng Y; Ruan Y; Shao Y
    Clin Infect Dis; 2016 Jul; 63(1):108-14. PubMed ID: 27001800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of nonsuppressed viral load and associated factors among HIV-positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population-based nationally representative surveys.
    Haas AD; Radin E; Hakim AJ; Jahn A; Philip NM; Jonnalagadda S; Saito S; Low A; Patel H; Schwitters AM; Rogers JH; Frederix K; Kim E; Bello G; Williams DB; Parekh B; Sachathep K; Barradas DT; Kalua T; Birhanu S; Musuka G; Mugurungi O; Tippett Barr BA; Sleeman K; Mulenga LB; Thin K; Ao TT; Brown K; Voetsch AC; Justman JE
    J Int AIDS Soc; 2020 Nov; 23(11):e25631. PubMed ID: 33225559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009.
    Blair JM; Fagan JL; Frazier EL; Do A; Bradley H; Valverde EE; McNaghten A; Beer L; Zhang S; Huang P; Mattson CL; Freedman MS; Johnson CH; Sanders CC; Spruit-McGoff KE; Heffelfinger JD; Skarbinski J;
    MMWR Suppl; 2014 Jun; 63(5):1-22. PubMed ID: 24941443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initiation of antiretroviral therapy based on the 2015 WHO guidelines.
    Kuznik A; Iliyasu G; Habib AG; Musa BM; Kambugu A; Lamorde M
    AIDS; 2016 Nov; 30(18):2865-2873. PubMed ID: 27662547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attrition when providing antiretroviral treatment at CD4 counts >500cells/μL at three government clinics included in the HPTN 071 (PopART) trial in South Africa.
    Bock P; Fatti G; Ford N; Jennings K; Kruger J; Gunst C; Louis F; Grobbelaar N; Shanaube K; Floyd S; Grimwood A; Hayes R; Ayles H; Fidler S; Beyers N;
    PLoS One; 2018; 13(4):e0195127. PubMed ID: 29672542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short Communication: Early Antiretroviral Therapy Is Associated with Better Viral Suppression and Less HIV Drug Resistance After Implementation of Universal Treatment in South Africa.
    Dorward J; Drain PK; Osman F; Sookrajh Y; Pillay M; Moodley P; Garrett N
    AIDS Res Hum Retroviruses; 2020 Apr; 36(4):297-299. PubMed ID: 31663368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of "test and treat" recommendations on eligibility for antiretroviral treatment: Cross sectional population survey data from three high HIV prevalence countries.
    Chihana ML; Huerga H; Van Cutsem G; Ellman T; Wanjala S; Masiku C; Szumilin E; Etard JF; Davies MA; Maman D
    PLoS One; 2018; 13(11):e0207656. PubMed ID: 30475865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barriers to antiretroviral initiation in HIV-1-discordant couples.
    Guthrie BL; Choi RY; Liu AY; Mackelprang RD; Rositch AF; Bosire R; Manyara L; Gatuguta A; Kiarie JN; Farquhar C
    J Acquir Immune Defic Syndr; 2011 Nov; 58(3):e87-93. PubMed ID: 21826010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4+ T Cell Recovery and Hepatitis B Virus Coinfection in HIV-Infected Patients from Côte d'Ivoire Initiating Antiretroviral Therapy.
    Houghtaling L; Moh R; Abdou Chekaraou M; Gabillard D; Anglaret X; Eholié SP; Zoulim F; Danel C; Lacombe K; Boyd A
    AIDS Res Hum Retroviruses; 2018 May; 34(5):439-445. PubMed ID: 29466862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update January 2007)].
    ;
    Enferm Infecc Microbiol Clin; 2007 Jan; 25(1):32-53. PubMed ID: 17261244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.
    Siegfried N; Uthman OA; Rutherford GW
    Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD008272. PubMed ID: 20238364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 'Then her neighbour will not know her status': how health providers advocate antiretroviral therapy under universal test and treat.
    Pell C; Reis R; Dlamini N; Moyer E; Vernooij E
    Int Health; 2019 Jan; 11(1):36-41. PubMed ID: 30137387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection.
    Lok JJ; Bosch RJ; Benson CA; Collier AC; Robbins GK; Shafer RW; Hughes MD;
    AIDS; 2010 Jul; 24(12):1867-76. PubMed ID: 20467286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A model for reduced HIV-1 viral load monitoring in resource-limited settings.
    Bryant L; Smith N; Keiser P
    J Int Assoc Provid AIDS Care; 2013; 12(1):67-71. PubMed ID: 22553318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.